# Sacituzumab Govitecan (Genetical Recombination) for I.V. Infusion 200mg (トロデルビ点滴静注用２００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291472D1026). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291472D1026
- **Product name (Japanese):** トロデルビ点滴静注用２００ｍｇ
- **English title:** Sacituzumab Govitecan (Genetical Recombination) for I.V. Infusion 200mg
- **Active ingredient:** サシツズマブ ゴビテカン（遺伝子組換え）
- **Active ingredient (INN):** Sacituzumab Govitecan (Genetical Recombination)
- **Strength / unit:** ２００ｍｇ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Gilead Sciences (ギリアド・サイエンシズ)
- **NHI price (reference only):** JPY 187195 per ２００ｍｇ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291472D1026
- **JSON:** https://www.nifujipharma.com/api/drugs/4291472D1026

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Sacituzumab%20Govitecan%20(Genetical%20Recombination)%20for%20I.V.%20Infusion%20200mg%20(%E3%83%88%E3%83%AD%E3%83%87%E3%83%AB%E3%83%93%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%92%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291472D1026#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.